Arcturus Therapeutics
ARCT
ARCT
6 hedge funds and large institutions have $11.8M invested in Arcturus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $4.64M | 676,735 | +676,735 | New |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $4.02M | 587,000 | +587,000 | New |
|
3
JPMorgan Chase & Co
New York
| $1.64M | 240,000 | +240,000 | New |
|
|
ACPU
4
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $1.26M | 184,041 | +184,041 | New |
|
|
TMC
5
Trellus Management Company
Delray Beach,
Florida
| $274K | 40,000 | +40,000 | New |
|
|
U
6
UBS
Zurich,
Switzerland
| $3K | 405 | +405 | New |
|